BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 37566027)

  • 21. FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis.
    Kabashi E; Bercier V; Lissouba A; Liao M; Brustein E; Rouleau GA; Drapeau P
    PLoS Genet; 2011 Aug; 7(8):e1002214. PubMed ID: 21829392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism.
    Keller BA; Volkening K; Droppelmann CA; Ang LC; Rademakers R; Strong MJ
    Acta Neuropathol; 2012 Nov; 124(5):733-47. PubMed ID: 22941224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced mitochondrial D-loop methylation levels in sporadic amyotrophic lateral sclerosis.
    Stoccoro A; Smith AR; Mosca L; Marocchi A; Gerardi F; Lunetta C; Cereda C; Gagliardi S; Lunnon K; Migliore L; Coppedè F
    Clin Epigenetics; 2020 Sep; 12(1):137. PubMed ID: 32917270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rodent Models of Amyotrophic Lateral Sclerosis.
    Philips T; Rothstein JD
    Curr Protoc Pharmacol; 2015 Jun; 69():5.67.1-5.67.21. PubMed ID: 26344214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SETX (senataxin), the helicase mutated in AOA2 and ALS4, functions in autophagy regulation.
    Richard P; Feng S; Tsai YL; Li W; Rinchetti P; Muhith U; Irizarry-Cole J; Stolz K; Sanz LA; Hartono S; Hoque M; Tadesse S; Seitz H; Lotti F; Hirano M; Chédin F; Tian B; Manley JL
    Autophagy; 2021 Aug; 17(8):1889-1906. PubMed ID: 32686621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
    Alrafiah AR
    In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Zou ZY; Zhou ZR; Che CH; Liu CY; He RL; Huang HP
    J Neurol Neurosurg Psychiatry; 2017 Jul; 88(7):540-549. PubMed ID: 28057713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China.
    Hou L; Jiao B; Xiao T; Zhou L; Zhou Z; Du J; Yan X; Wang J; Tang B; Shen L
    Sci Rep; 2016 Sep; 6():32478. PubMed ID: 27604643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis.
    Yousefian-Jazi A; Seol Y; Kim J; Ryu HL; Lee J; Ryu H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33333804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models.
    Kato S; Kato M; Abe Y; Matsumura T; Nishino T; Aoki M; Itoyama Y; Asayama K; Awaya A; Hirano A; Ohama E
    Acta Neuropathol; 2005 Aug; 110(2):101-12. PubMed ID: 15983830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy.
    Suzuki N; Nishiyama A; Warita H; Aoki M
    J Hum Genet; 2023 Mar; 68(3):131-152. PubMed ID: 35691950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Silico Exploration of Metabolically Active Peptides as Potential Therapeutic Agents against Amyotrophic Lateral Sclerosis.
    Fatoki TH; Chukwuejim S; Udenigwe CC; Aluko RE
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants.
    Bertolin C; D'Ascenzo C; Querin G; Gaiani A; Boaretto F; Salvoro C; Vazza G; Angelini C; Cagnin A; Pegoraro E; Sorarù G; Mostacciuolo ML
    Neurobiol Aging; 2014 May; 35(5):1212.e7-1212.e10. PubMed ID: 24325798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations of optineurin in amyotrophic lateral sclerosis.
    Maruyama H; Morino H; Ito H; Izumi Y; Kato H; Watanabe Y; Kinoshita Y; Kamada M; Nodera H; Suzuki H; Komure O; Matsuura S; Kobatake K; Morimoto N; Abe K; Suzuki N; Aoki M; Kawata A; Hirai T; Kato T; Ogasawara K; Hirano A; Takumi T; Kusaka H; Hagiwara K; Kaji R; Kawakami H
    Nature; 2010 May; 465(7295):223-6. PubMed ID: 20428114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study.
    Olsen CG; Busk ØL; Aanjesen TN; Alstadhaug KB; Bjørnå IK; Braathen GJ; Breivik KL; Demic N; Flemmen HØ; Hallerstig E; HogenEsch I; Holla ØL; Jøntvedt AB; Kampman MT; Kleveland G; Kvernmo HB; Ljøstad U; Maniaol A; Morsund ÅH; Nakken O; Novy C; Rekand T; Schlüter K; Schüler S; Tveten K; Tysnes OB; Holmøy T; Høyer H
    Neuroepidemiology; 2022; 56(4):271-282. PubMed ID: 35576897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS).
    Crippa V; Sau D; Rusmini P; Boncoraglio A; Onesto E; Bolzoni E; Galbiati M; Fontana E; Marino M; Carra S; Bendotti C; De Biasi S; Poletti A
    Hum Mol Genet; 2010 Sep; 19(17):3440-56. PubMed ID: 20570967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology.
    Ince PG; Highley JR; Kirby J; Wharton SB; Takahashi H; Strong MJ; Shaw PJ
    Acta Neuropathol; 2011 Dec; 122(6):657-71. PubMed ID: 22105541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS).
    Abati E; Bresolin N; Comi G; Corti S
    Expert Opin Ther Targets; 2020 Apr; 24(4):295-310. PubMed ID: 32125907
    [No Abstract]   [Full Text] [Related]  

  • 40. A patient carrying a heterozygous p.Asn267Ser TARDBP missense mutation diagnosed as ALS and only involving lower motor neurons.
    Jin S; Sun Z; Fang X; Chen H; Yang W
    Neurol Sci; 2023 Feb; 44(2):777-782. PubMed ID: 36527522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.